News & Events

Three biomedical startups presented at last week’s event:

• Novotalk: an online, on-demand, self-directed teletherapy solution, which allows those with speech impairments to learn, practice, gain and maintain comprehensible speech remotely, independently and discretely.
• Immunity Pharma: a company dedicated to developing innovative compounds that stimulate therapeutic cell-signaling processes for the treatment of ALS and other neurodegenerative diseases.
• Medivizor: a free, live, health information service which delivers personalized, summarized, and bottom-lined information to the patient’s inbox, so that they may be more knowledgeable about their condition and treatment options, and better able to collaborate with their healthcare provider.

“The TruMada Initiative is a great opportunity to foster collaboration between the services available at TruMada and New York Medical College and what Israeli biotechnology startups require in the areas of business development, capital formation and office and lab space,” said Lawrence Krule, the Chief Executive Officer of the TruMada Management Company LLC. “We are proud to shed light on the tremendous medical innovations coming out of Israel and bridge the gap of experience and knowledge to help these companies expand and commercialize in the U.S.”  

Following the presentations, attendees had an opportunity to express their interest in investing in each candidate. TruMada Management Company will facilitate the dialogue between investors and presenting companies. The event was the fourth in an on-going series aimed at connecting Israeli companies with the investing community.

TruMada Initiative

The TruMada Initiative, through TruMada Management Company and BioInc@NYMC , helps post-incubated Israeli biomedical startups commercialize and establish their company in the U.S. market. BioInc@NYMC is the Hudson Valley’s only biotechnology incubator offering shared resources, turn-key wet lab space, and sponsored professional services to promising, high-potential entrepreneurs and start-ups. In addition to providing best-in-class infrastructure and operational services, BioInc@NYMC assists its members in refining their business strategies, conserving capital, building strong teams, and achieving development and funding milestones.

New York Medical College

Founded in 1860, New York Medical College is one of the oldest and largest health sciences colleges in the country with nearly 1,500 students and 330 residents and clinical fellows, more than 2,600 faculty members and 23,200 living alumni. The College, which joined the Touro College and University System in 2011, is located in Westchester County, New York, and offers degrees from the School of Medicine, the Graduate School of Basic Medical Sciences, the School of Health Sciences and Practice, a School of Dental Medicine and a School of Nursing. NYMC provides a wide variety of clinical training opportunities for students, residents, and practitioners.

The Touro College and University System

Touro is a system of non-profit institutions of higher and professional education. Touro College was chartered in 1970 primarily to enrich the Jewish heritage, and to serve the larger American and global community. Approximately 18,000 students are currently enrolled in its various schools and divisions. Touro College has 29 branch campuses, locations and instructional sites in the New York area, as well as branch campuses and programs in Berlin, Jerusalem and Moscow. New York Medical College; Touro University California and its Nevada branch campus; Touro University Worldwide and its Touro College Los Angeles division; as well as Hebrew Theological College in Skokie, Ill. are separately accredited institutions within the Touro College and University System. For further information on Touro College, please go to:  http://www.touro.edu/news/.